TABLE 1.
Summary of studies showing enhanced response of cytotoxic chemotherapy in combination with pharmacologic inhibition of autophagy
Therapeutic Agent | Model | Autophagy Inhibition | Response | Reference |
---|---|---|---|---|
Temozolomide | Human malignant glioma cell lines | 3-Methyladenine | Decreased cytotoxicity | Kanzawa et al., 2004 |
Bafilomycin A | Increased cytotoxicity | |||
Cyclophosphamide | Murine Myc-induced lymphoma cancer | Chloroquine | Increased antitumor response | Amaravadi et al., 2007 |
5-Fluorouracil | Human colon cancer cell lines | 3-Methyladenine | Increased apoptosis | Li et al., 2009 |
5-Fluorouracil | Human colon cancer cell lines and xenograft | Increased cytotoxicity | Li et al., 2010 | |
5-Fluorouracil | Human colon cancer cell line (HT29) | Chloroquine | Increased cytotoxicity | Sasaki et al., 2010 |
5-Fluorouracil | Human hepatic carcinoma cell lines | 3-Methyladenine | Increased apoptosis | Guo et al., 2012 |
5-Fluorouracil | Murine colon cancer cell line and tumor xenograft | Chloroquine | Increased apoptosis | Sasaki et al., 2012 |
5-Fluorouracil | Human NSCLC cell line (A549) | 3-Methyladenine | Increased apoptosis | Pan et al., 2013 |
Cisplatin | Esophageal SSC cell line (EC9706) | 3-Methyladenine | Increased apoptosis | Liu et al., 2011a |
Cisplatin | Human cholangiocarcinoma cell lines | 3-Methyladenine | Increased cytotoxicity | Hou et al., 2011 |
Wortmannin | ||||
Cisplatin | Human cervical cancer cell line (HeLa) | 3-Methyladenine | Increased apoptosis | Xu et al., 2012 |
Chloroquine | ||||
Cisplatin | Human hepatic carcinoma cell lines | 3-Methyladenine | Increased apoptosis | Guo et al., 2012 |
Cisplatin | Laryngeal cancer cells (Hep-2) | 3-Methyladenine | Increased apoptosis | Kang et al., 2012 |
Cisplatin | Human NSLC cell line (A549) | 3-Methyladenine | Increased apoptosis | Liu et al., 2013 |
Oxaliplatin | Human colon cancer cell lines and xenograft | Chloroquine | Increased cytotoxicity and tumor control | Selvakumaran et al., 2013 |
Paclitaxel | Human NSLC cell line (A549) | 3-Methyladenine | Increased apoptosis | Liu et al., 2013 |
Etoposide | Human hepatocellular carcinoma cell line (HepG2) | 3-Methyladenine | Increased cytotoxicity | Xie et al., 2011 |
Doxorubicin | Human multiple myeloma cell lines, patient-derived multiple myeloma cells, human plasmacytoma xenograft | Hydroxychloroquine | Increased apoptosis | Pan et al., 2011 |
3-Methyladenine | ||||
Epirubicin | Human breast cancer cell line (MCF7) | Bafilomycin A | Increased apoptosis | Sun et al., 2011 |
Melphalan | Human multiple myeloma cell lines, patient-derived multiple myeloma cells, human plasmacytoma xenograft | Hydroxychloroquine | Increased apoptosis | Pan et al., 2011 |
3-Methyladenine | ||||
Topotecan | Human NSLC cell line (A549) | Chloroquine | Increased cytotoxicity | Wang et al., 2011 |
Camptothecin | Human breast cancer cell lines | Wortmannin | Increased apoptosis in selective cell lines | Abedin et al., 2007 |
3-Methlyadenine | ||||
Bafilomycin A |